A detailed history of Parallel Advisors, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Parallel Advisors, LLC holds 4,617 shares of BDX stock, worth $1.05 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,617
Previous 4,569 1.05%
Holding current value
$1.05 Million
Previous $1.07 Million 4.31%
% of portfolio
0.03%
Previous 0.03%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$221.47 - $242.41 $10,630 - $11,635
48 Added 1.05%
4,617 $1.11 Million
Q2 2024

Aug 08, 2024

BUY
$225.07 - $246.17 $35,561 - $38,894
158 Added 3.58%
4,569 $1.07 Million
Q1 2024

May 06, 2024

SELL
$233.45 - $247.73 $60,930 - $64,657
-261 Reduced 5.59%
4,411 $1.09 Million
Q4 2023

Feb 09, 2024

SELL
$232.24 - $267.23 $159,084 - $183,052
-685 Reduced 12.79%
4,672 $1.14 Million
Q3 2023

May 20, 2024

SELL
$254.9 - $283.59 $254 - $283
-1 Reduced 0.02%
5,357 $1.38 Million
Q3 2023

Nov 13, 2023

SELL
$254.9 - $283.59 $254 - $283
-1 Reduced 0.02%
5,357 $1.38 Million
Q2 2023

May 20, 2024

BUY
$238.39 - $265.32 $24,792 - $27,593
104 Added 1.98%
5,358 $1.41 Million
Q2 2023

Aug 04, 2023

BUY
$238.39 - $265.32 $24,792 - $27,593
104 Added 1.98%
5,358 $1.41 Million
Q1 2023

May 20, 2024

BUY
$229.71 - $259.35 $193,645 - $218,632
843 Added 19.11%
5,254 $1.3 Million
Q1 2023

Apr 25, 2023

BUY
$229.71 - $259.35 $696,710 - $786,608
3,033 Added 136.56%
5,254 $1.3 Million
Q4 2022

Feb 03, 2023

SELL
$218.29 - $256.91 $188,165 - $221,456
-862 Reduced 27.96%
2,221 $564,000
Q3 2022

Nov 10, 2022

SELL
$51.03 - $264.23 $15,309 - $79,269
-300 Reduced 8.87%
3,083 $687,000
Q2 2022

Aug 01, 2022

SELL
$234.74 - $275.42 $9,154 - $10,741
-39 Reduced 1.14%
3,383 $834,000
Q1 2022

Apr 28, 2022

SELL
$243.64 - $270.48 $30,211 - $33,539
-124 Reduced 3.5%
3,422 $922,000
Q4 2021

Jan 20, 2022

BUY
$230.08 - $250.94 $121,482 - $132,496
528 Added 17.5%
3,546 $892,000
Q3 2021

Nov 02, 2021

BUY
$232.72 - $256.47 $140,795 - $155,164
605 Added 25.07%
3,018 $742,000
Q2 2021

Aug 06, 2021

SELL
$232.65 - $254.58 $18,612 - $20,366
-80 Reduced 3.21%
2,413 $587,000
Q1 2021

Apr 23, 2021

BUY
$232.09 - $256.88 $103,280 - $114,311
445 Added 21.73%
2,493 $606,000
Q4 2020

Feb 02, 2021

BUY
$221.92 - $245.94 $29,515 - $32,710
133 Added 6.95%
2,048 $512,000
Q3 2020

Oct 27, 2020

BUY
$215.77 - $276.76 $49,195 - $63,101
228 Added 13.52%
1,915 $446,000
Q2 2020

Jul 16, 2020

SELL
$219.9 - $263.41 $1,979 - $2,370
-9 Reduced 0.53%
1,687 $403,000
Q1 2020

Apr 27, 2020

BUY
$195.69 - $279.01 $17,025 - $24,273
87 Added 5.41%
1,696 $389,000
Q4 2019

Jan 30, 2020

SELL
$236.45 - $266.82 $4,965 - $5,603
-21 Reduced 1.29%
1,609 $438,000
Q3 2019

Nov 01, 2019

BUY
$230.58 - $256.08 $50,497 - $56,081
219 Added 15.52%
1,630 $412,000
Q2 2019

Aug 05, 2019

BUY
$217.4 - $246.08 $14,348 - $16,241
66 Added 4.91%
1,411 $356,000
Q1 2019

May 01, 2019

SELL
$206.05 - $248.17 $26,580 - $32,013
-129 Reduced 8.75%
1,345 $336,000
Q4 2018

Feb 05, 2019

BUY
$204.73 - $257.93 $16,173 - $20,376
79 Added 5.66%
1,474 $332,000
Q3 2018

Nov 01, 2018

BUY
$233.07 - $256.0 $29,832 - $32,768
128 Added 10.1%
1,395 $364,000
Q2 2018

Jul 30, 2018

BUY
$208.1 - $233.85 $9,156 - $10,289
44 Added 3.6%
1,267 $303,000
Q1 2018

May 08, 2018

BUY
$205.46 - $240.27 $28,969 - $33,878
141 Added 13.03%
1,223 $265,000
Q4 2017

Feb 13, 2018

BUY
$189.0 - $222.64 $4,347 - $5,120
23 Added 2.17%
1,082 $232,000
Q3 2017

Nov 15, 2017

BUY
$186.89 - $198.9 $197,916 - $210,635
1,059 New
1,059 $233,000
Q3 2017

Nov 14, 2017

SELL
$186.89 - $198.9 $192,496 - $204,867
-1,030 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
1,030
1,030 $207,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.